Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026

What the insiders did Net selling

By person

21 insiders · 142 transactions
5.8×

David Moatazedi holds 5.8 times base salary in stock. $4.52M of shares against $775.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David Moatazedi last reported holding, valued at $9.04, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
AEON Biopharma, Inc. entity
Former 10% Owner
—
$190.83M (7)
−$190.83M
0
$0.00
−100.0%
Alphaeon 1 LLC entity
10% owner
—
$40.22M (2)
−$40.22M
10,279,742
$92.91M
−30.2%
Medytox Inc. entity
Former 10% Owner
$8.06M (15)
$33.81M (10)
−$25.75M
10,640,826
$96.18M
−24.1%
Vikram Malik
Director
$26.65M (4)
$2.09M (7)
+$24.56M
1,464,810
$13.24M
+6,659%
David Moatazedi
See Remarks
—
$16.48M (29)
−$16.48M
499,592
$4.52M
—
Simone Blank
Director
$16.41M (3)
—
+$16.41M
927,471
$8.38M
—
Rui Avelar
See Remarks
—
$1.91M (15)
−$1.91M
427,423
$3.86M
+326.5%
Kristine Romine
Director
$1.54M (11)
—
+$1.54M
84,359
$762.48K
—
Lauren P Silvernail
See Remarks
—
$1.19M (6)
−$1.19M
141,571
$1.28M
—
Sandra Beaver
Chief Financial Officer
—
$437.75K (9) scheduled
−$437.75K
167,089
$1.51M
—
Karah Herdman Parschauer
Director
—
$324.20K (2)
−$324.20K
77,742
$702.67K
—
Bosun Hau
Director
$309.73K (2)
—
+$309.73K
10,040
$90.75K
—
Michael M. Jafar
See Remarks
$266.59K (1)
$20.13K (1)
+$246.46K
219,851
$1.99M
+109,826%
Brady Stewart
Director
$204.49K (1)
—
+$204.49K
134,188
$1.21M
—
David N Gill
Director
$65.60K (2)
$268.67K (4)
−$203.07K
86,887
$785.33K
—
Tomoko Yamagishi-Dressler
Chief Marketing Officer
—
$192.35K (3) scheduled
−$192.35K
89,949
$813.00K
—
Albert G White III
Director
$189.00K (1)
—
+$189.00K
95,937
$867.13K
—
Robert Hayman
Director
$153.86K (3)
—
+$153.86K
65,222
$589.51K
+197,542%
Crystal Muilenburg
Chief Marketing Officer
—
$123.11K (2)
−$123.11K
134,248
$1.21M
+57.2%
Peter C Farrell
Director
$91.05K (1)
—
+$91.05K
53,174
$480.61K
—
Tatjana Mitchell
Chief Financial Officer
—
—
—
226,092
$2.04M
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.